Latest filing published 01 Mar 2006 for VIROPHARMA INC, €920k.
Insider track record
No signal scores available.
Baker Biotech Capital II (GP), LLC: trading record in brief
Baker Biotech Capital II (GP), LLC discloses dealings in Viropharma Inc to SEC (Form 4). Between 27 February 2006 and 28 February 2006, the trades on record add up to 6 filings.
No open-market purchase appears, only 6 sales worth €3.9M.
The newest entry dates from 1 March 2006: an open-market sale of €920k, in Viropharma Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Baker Biotech Capital II (GP), LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 50,123 shares@ US$21.743Common StockSEC:0001144204-06-008349:0
- 50,725 shares@ US$21.7242Common StockSEC:0001144204-06-008349:1
- 11,370 shares@ US$21.5799Common StockSEC:0001144204-06-008349:2
- 210 shares@ US$21.8063Common StockSEC:0001144204-06-008349:3
- 74,394 shares@ US$19.8953Common StockSEC:0001144204-06-008349:4
- 36,590 shares@ US$20.4109Common StockSEC:0001144204-06-008349:5
6 of 6 declarations